1. Home
  2. TGTX vs AG Comparison

TGTX vs AG Comparison

Compare TGTX & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$55.16

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Logo First Majestic Silver Corp. (Canada)

AG

First Majestic Silver Corp. (Canada)

HOLD

Current Price

$17.46

Market Cap

8.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGTX
AG
Founded
1993
1979
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.4B
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
TGTX
AG
Price
$55.16
$17.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$49.80
$21.92
AVG Volume (30 Days)
2.8M
11.6M
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
0.12%
EPS Growth
1746.67
N/A
EPS
0.12
N/A
Revenue
$2,785,000.00
N/A
Revenue This Year
$49.08
$24.41
Revenue Next Year
$26.69
$10.68
P/E Ratio
$457.67
$143.01
Revenue Growth
N/A
N/A
52 Week Low
$25.37
$7.74
52 Week High
$57.38
$32.00

Technical Indicators

Market Signals
Indicator
TGTX
AG
Relative Strength Index (RSI) 77.96 45.78
Support Level $28.57 $15.61
Resistance Level $57.38 $20.00
Average True Range (ATR) 2.39 0.94
MACD 0.24 0.05
Stochastic Oscillator 81.53 41.71

Price Performance

Historical Comparison
TGTX
AG

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.

Share on Social Networks: